https://www.insurerbrain.com/w/index.php?action=history&feed=atom&title=Definition%3ASubstance_use_disorder 2026-05-09T15:13:26Z Revision history for this page on the wiki MediaWiki 1.43.8 https://www.insurerbrain.com/w/index.php?title=Definition:Substance_use_disorder&diff=11928&oldid=prev 2026-03-12T00:58:20Z

<p>Bot: Creating new article from JSON</p> <p><b>New page</b></p><div>🩺 &#039;&#039;&#039;Substance use disorder&#039;&#039;&#039; is a medical condition characterized by the compulsive use of alcohol, opioids, or other substances despite harmful consequences, and it occupies a significant position in insurance because of its impact on [[Definition:Health insurance | health]], [[Definition:Life insurance | life]], [[Definition:Disability insurance | disability]], and [[Definition:Workers&#039; compensation insurance | workers&#039; compensation]] [[Definition:Underwriting | underwriting]], [[Definition:Claims management | claims costs]], and [[Definition:Regulatory compliance | regulatory mandates]]. The condition is recognized as a chronic, treatable illness under prevailing medical standards, a classification that has fundamentally shaped how insurers must cover it under federal and state [[Definition:Mental health parity | mental health parity]] laws.<br /> <br /> 🔎 Under the [[Definition:Mental Health Parity and Addiction Equity Act | Mental Health Parity and Addiction Equity Act]] and reinforcing provisions in the Affordable Care Act, [[Definition:Insurance carrier | insurers]] offering [[Definition:Group health insurance | group]] or individual health plans cannot impose more restrictive [[Definition:Benefit limitation | benefit limitations]] — such as higher [[Definition:Copayment | copayments]], lower visit caps, or stricter [[Definition:Prior authorization | prior authorization]] criteria — on substance use disorder treatment than they apply to comparable medical and surgical benefits. Compliance is operationally demanding: carriers must perform quantitative and non-quantitative treatment limitation analyses across every [[Definition:Benefit classification | benefit classification]], document their methodologies, and respond to regulatory audits. On the [[Definition:Life insurance | life]] and [[Definition:Disability insurance | disability]] side, substance use history factors into [[Definition:Risk classification | risk classification]] decisions, though evolving legal and social norms are pushing underwriters to distinguish more carefully between active disorders and sustained recovery.<br /> <br /> 📊 The financial stakes are substantial. Substance use disorders drive significant [[Definition:Claim | claims]] volume across multiple lines — inpatient rehabilitation, medication-assisted treatment, emergency department utilization, and long-term disability payments. Opioid-related claims alone have cost the U.S. insurance system billions of dollars and prompted [[Definition:Insurance carrier | carriers]] to pursue [[Definition:Subrogation | subrogation]] and litigation against pharmaceutical manufacturers. For [[Definition:Health insurance | health insurers]] and [[Definition:Managed care organization | managed care organizations]], investing in evidence-based [[Definition:Care management | care management]] programs for substance use disorders is both a compliance imperative and a cost-containment strategy, since effective early intervention can reduce downstream hospitalizations, relapse cycles, and associated [[Definition:Loss ratio (L/R) | medical loss]].<br /> <br /> &#039;&#039;&#039;Related concepts:&#039;&#039;&#039;<br /> {{Div col|colwidth=20em}}<br /> * [[Definition:Mental health parity]]<br /> * [[Definition:Mental Health Parity and Addiction Equity Act]]<br /> * [[Definition:Health insurance]]<br /> * [[Definition:Disability insurance]]<br /> * [[Definition:Prior authorization]]<br /> * [[Definition:Care management]]<br /> {{Div col end}}</div>

PlumBot